Advertisement

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform

Thursday, June 30, 2022

Inceptor Bio a biotechnology company advancing cell therapies for difficulttotreat cancers today announced a collaboration with University of Minnesota The aim of this collaboration is to build a novel induced pluripotent stem cells iPSC platform tha...

Akebia Therapeutics Regaining Rights to Vadadustat in the United States, Europe, China and Access Consortium Countries upon Termination of Collaboration and License Agreements with Otsuka

Thursday, June 30, 2022

Akebia Therapeutics Inc a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease today announced that it has executed an agreement to terminate the US and exUS vadadustat Collaboration and License Agreemen...

Nurix Therapeutics Announces Clearance of Investigational New Drug Application For NX-1607 Supporting Plans to Expand Enrollment to U.S. Clinical Sites

Thursday, June 30, 2022

Nurix Therapeutics Inc a clinical stage biopharmaceutical company developing targeted protein modulation drugs today announced that it has received clearance from the US Food and Drug Administration FDA for the companys Investigational New Drug IND a...

Ocuphire Granted New U.S. Patent for Late-Stage Oral Drug Candidate APX3330 for Use in Diabetics and Announces New Peer-Reviewed APX3330 Publication

Wednesday, June 29, 2022

Ocuphire Pharma Inc a clinicalstage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders today announced that the United States Patent and Trademark Office...

EYLEA® (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review

Wednesday, June 29, 2022

Regeneron Pharmaceuticals Inc announced the US Food and Drug Administration FDA has accepted for review the EYLEA aflibercept Injection supplemental Biologics License Application sBLA for an every week mg dosing regimen after initial monthly doses i...

Apnimed Granted FDA Fast Track Designation for AD109, a Novel First-in-Class Oral Pharmacologic Combination for the Treatment of Obstructive Sleep Apnea (OSA)

Tuesday, June 28, 2022

Apnimed a clinicalstage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea OSA and related disorders announced today that the US Food and Drug Administration FDA has granted Fast Track design...

Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®

Tuesday, June 28, 2022

Evofem Biosciences Inc today announced it has reached an agreement with one of the nations largest pharmacy benefit managers PBMs to ensure most women covered by this plan can fill their Phexxi lactic acid citric acid potassium bitartrate prescriptio...

Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

Tuesday, June 28, 2022

Beyond Air Inc a clinicalstage medical device and biopharmaceutical company focused on developing inhaled nitric oxide NO for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension and throu...

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

Tuesday, June 28, 2022

ProPhase Labs Inc a diversified diagnostics and genomics company today announced the formation of whollyowned subsidiary ProPhase BioPharma Inc PBIO for the licensing and development of novel drugs compounds and biotechnology PBIO will focus on advan...

Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills

Tuesday, June 28, 2022

With the realization of the first successful customer fills Vetter a leading global Contract Development and Manufacturing Organization CDMO has reached another milestone at its new clinical manufacturing facility in Rankweil Austria Further batches...